Medication info
Glucera Tablets 500 mg (Metformin Hydrochloride)

Glucera Tablets 500 mg (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
(Samchundang Pharmaceuticals Co., Ltd.)
Appearance
White round film-coated tablet
Packaging
300 tablets/bottle
Approval status
Active

MFDS item code 200001344 · Notified 2000.01.28 · Insurance code 651200020

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on therapeutic response and tolerability and should not exceed the recommended maximum daily dose. This medicine must be started at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Take 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. If the dose exceeds 2000mg, divide it into 3 doses daily and take with meals. The maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess response to treatment with this medicine and identify the minimum effective dose. Measure blood glycosylated hemoglobin levels approximately every 3 months. The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled by diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other conditions that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.
Child dose
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Ingredients

Manufacturer
(Samchundang Pharmaceuticals Co., Ltd.)

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes
View approved original text

This medication is used for the treatment of patients with type 2 diabetes whose blood sugar levels cannot be controlled by diet and exercise alone. It can be used either alone or in combination with other oral antidiabetic agents or insulin in adult patients who are particularly overweight, helping with blood sugar control. Additionally, it can be used alone or with insulin in children aged 10 years and older, making it effective for blood sugar management across various age groups. Overall, this medication is actively used in patients struggling with blood sugar control to treat diabetes.

How to take

Adult dose

The dose should be determined individually based on therapeutic response and tolerability and should not exceed the recommended maximum daily dose. This medicine must be started at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Take 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. If the dose exceeds 2000mg, divide it into 3 doses daily and take with meals. The maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess response to treatment with this medicine and identify the minimum effective dose. Measure blood glycosylated hemoglobin levels approximately every 3 months. The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled by diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other conditions that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.

Child dose

Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia and should not be used, especially in patients with impaired kidney function or acute conditions such as infection and heart failure. It should not be administered to patients with moderate to severe kidney impairment, dehydration, serious infection, or acute myocardial infarction, which may affect kidney function. Patients with acute or unstable heart failure, those undergoing radiologic iodine contrast examinations, and those with hypersensitivity to this medication or similar drugs should also not be treated with it. This medication is not to be used in patients with type 1 diabetes or those with diabetic ketoacidosis or diabetic pre-coma. Patients with severe infections or serious trauma causing systemic disorders should discontinue this medication until oral intake recovers and kidney function normalizes. Patients scheduled for surgery should stop this medication 48 hours prior to surgery and restart only after confirming normal kidney function post-surgery. This medication should be used with caution in cases of malnutrition, starvation, weakness, pituitary dysfunction, or adrenal insufficiency. Patients with liver dysfunction or pulmonary dysfunction, those consuming excessive alcohol, or those experiencing dehydration, diarrhea, or vomiting require careful monitoring when using this medication. This medication may rarely cause lactic acidosis, which can be fatal, so both patients and healthcare providers should closely monitor for symptoms of lactic acidosis such as fatigue, muscle pain, difficulty breathing, weakness, and abdominal pain. During treatment, gastrointestinal symptoms such as diarrhea, nausea, vomiting, and abdominal distension may occur, generally transient, but dosage adjustment may be necessary if severe. This medication lowers blood sugar but carries a risk of hypoglycemia, especially when used with other antidiabetic agents or when food intake is insufficient, necessitating caution. If kidney function is decreased, this medication can accumulate in the body, increasing the risk of side effects; thus, regular kidney function tests should be conducted before and during treatment. Alcohol can affect the metabolism of this medication, increasing the risk of lactic acidosis, so excessive drinking should be avoided during treatment. In pregnant women, this medication can cross the placenta and affect the fetus. It should be avoided in cases where there is a risk of placental insufficiency or pre-eclampsia and used cautiously only when blood sugar control is critically needed during pregnancy. Breastfeeding women should carefully decide whether to continue breastfeeding or discontinue the medication, as this medication is excreted in breast milk. Elderly individuals commonly experience reduced kidney function; therefore, treatment should start at the minimum dosage, with regular monitoring of kidney function and avoidance of maximum dosage. In case of overdose, blood dialysis can remove the drug, so patients should immediately inform healthcare providers and receive appropriate treatment. This medication interacts with various other drugs; therefore, if patients are taking other medications, they should inform their healthcare providers, and blood sugar changes and patients' conditions must be monitored closely. During treatment, regular meals and exercise, along with periodic blood sugar and kidney function testing, are crucial, and patients should consult healthcare providers immediately if any abnormal symptoms occur.

Side effects

  • lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent air and moisture exposure. Additionally, when storing the medication, it is important to maintain a temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.